aTyr Pharma LIFE reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
aTyr Pharma missed estimated earnings by 15.79%, reporting an EPS of $-0.44 versus an estimate of $-0.38.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 3.06% drop in the share price the next day.
Here's a look at aTyr Pharma's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for aTyr Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.